Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis

Centre Oscar Lambret110 enrolled

Overview

The aim of this study is to identify prognostic factors for outcome in patients being complete clinical responders with chemoradiation or radiation for esophageal cancer

Study Type

OBSERVATIONAL

Enrollment

110

Conditions

Esophageal Cancer

Interventions

ChemotherapyDRUG

Chemotherapy according to standard

RadiotherapyRADIATION

Radiotherapy according to local standard

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * localized or locally advanced esophageal cancer * patient who underwent definite chemoradiation or radiation * patient with complete clinical response Exclusion Criteria: * metastatic disease

Locations (1)

Centre Oscar LAMBRET

Lille, France

Outcomes

Primary Outcomes

Identification of prognostic factors for overall survival

Correlation between survival and baseline,clinical and treatment characteristics

Time frame: From date of treatment until death, assessed up to 10 years

Secondary Outcomes

Patterns of treatment failure

Type of recurrence : local, regional, distant.

Time frame: From date of treatment until treatment failure, assessed up to 10 years

Disease-free survival

Time between the end of treatment and the occurence of progression

Time frame: From date of treatment until progression or death, assessed up to 10 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.